 | • レポートコード：QYR2104Z1274 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、化学療法誘発性悪心・嘔吐（CINV）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（CINV、PONV）、用途別市場規模（病院、外来手術センター、診断センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・化学療法誘発性悪心・嘔吐（CINV）の市場動向 ・企業の競争状況、市場シェア ・化学療法誘発性悪心・嘔吐（CINV）の種類別市場規模（CINV、PONV） ・化学療法誘発性悪心・嘔吐（CINV）の用途別市場規模（病院、外来手術センター、診断センター） ・化学療法誘発性悪心・嘔吐（CINV）の北米市場規模2016-2027（アメリカ、カナダ） ・化学療法誘発性悪心・嘔吐（CINV）のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・化学療法誘発性悪心・嘔吐（CINV）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・化学療法誘発性悪心・嘔吐（CINV）の中南米市場規模2016-2027（メキシコ、ブラジル） ・化学療法誘発性悪心・嘔吐（CINV）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Merck、Eisai、ProStrakan、Helsinn Holding、Mundipharma、Qilu Pharma、Teva、Novartis、Heron Therapeutics、Roche、Mylan、Tesaro） ・結論 |
Chemotherapy-Induced Nausea and Vomiting (CINV) is one of the devastating side effects for patients undergoing cancer treatment. It is caused when various types of poisonous substances such as chemotherapeutic agents enter in the human body and alert the digestive system during chemotherapy. Besides chemotherapy, there are various types of factors that puts a patient high risk for CINV including female sex, history of alcohol use, CINV & motion sickness and anxiety or depression.
The global CINV & PONV market is expected to grow with increasing cancer incidence, growing female population, increasing pharmaceutical R&D spending, growing healthcare expenditure and accelerating economic growth. Key trends and developments of this market includes progressing drugs under pipeline, high demand for combination therapy and increasing preference for pressure point therapy. However, there are some factors which can hinder growth of the market including entry of generics, stringent regulations and treatment cost.
Market Analysis and Insights: Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market
The global Chemotherapy-Induced Nausea and Vomiting (CINV) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Chemotherapy-Induced Nausea and Vomiting (CINV) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Chemotherapy-Induced Nausea and Vomiting (CINV) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Chemotherapy-Induced Nausea and Vomiting (CINV) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Chemotherapy-Induced Nausea and Vomiting (CINV) market.
Global Chemotherapy-Induced Nausea and Vomiting (CINV) Scope and Market Size
Chemotherapy-Induced Nausea and Vomiting (CINV) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Chemotherapy-Induced Nausea and Vomiting (CINV) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
CINV
PONV
Segment by Application
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Merck
Eisai
ProStrakan
Helsinn Holding
Mundipharma
Qilu Pharma
Teva
Novartis
Heron Therapeutics
Helsinn Holding
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 CINV
1.2.3 PONV
1.3 Market by Application
1.3.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Perspective (2016-2027)
2.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Growth Trends by Regions
2.2.1 Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Historic Market Share by Regions (2016-2021)
2.2.3 Chemotherapy-Induced Nausea and Vomiting (CINV) Forecasted Market Size by Regions (2022-2027)
2.3 Chemotherapy-Induced Nausea and Vomiting (CINV) Industry Dynamic
2.3.1 Chemotherapy-Induced Nausea and Vomiting (CINV) Market Trends
2.3.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Market Drivers
2.3.3 Chemotherapy-Induced Nausea and Vomiting (CINV) Market Challenges
2.3.4 Chemotherapy-Induced Nausea and Vomiting (CINV) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chemotherapy-Induced Nausea and Vomiting (CINV) Players by Revenue
3.1.1 Global Top Chemotherapy-Induced Nausea and Vomiting (CINV) Players by Revenue (2016-2021)
3.1.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Players (2016-2021)
3.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue
3.4 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Concentration Ratio
3.4.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in 2020
3.5 Chemotherapy-Induced Nausea and Vomiting (CINV) Key Players Head office and Area Served
3.6 Key Players Chemotherapy-Induced Nausea and Vomiting (CINV) Product Solution and Service
3.7 Date of Enter into Chemotherapy-Induced Nausea and Vomiting (CINV) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chemotherapy-Induced Nausea and Vomiting (CINV) Breakdown Data by Type
4.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Historic Market Size by Type (2016-2021)
4.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Forecasted Market Size by Type (2022-2027)
5 Chemotherapy-Induced Nausea and Vomiting (CINV) Breakdown Data by Application
5.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Historic Market Size by Application (2016-2021)
5.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (2016-2027)
6.2 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type
6.2.1 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2016-2021)
6.2.2 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2022-2027)
6.2.3 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2016-2027)
6.3 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application
6.3.1 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2016-2021)
6.3.2 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2022-2027)
6.3.3 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2016-2027)
6.4 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country
6.4.1 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2016-2021)
6.4.2 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (2016-2027)
7.2 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type
7.2.1 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2016-2021)
7.2.2 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2022-2027)
7.2.3 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2016-2027)
7.3 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application
7.3.1 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2016-2021)
7.3.2 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2022-2027)
7.3.3 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2016-2027)
7.4 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country
7.4.1 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2016-2021)
7.4.2 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (2016-2027)
8.2 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type
8.2.1 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2016-2027)
8.3 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application
8.3.1 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2016-2027)
8.4 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Region
8.4.1 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (2016-2027)
9.2 Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type
9.2.1 Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2016-2021)
9.2.2 Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2022-2027)
9.2.3 Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2016-2027)
9.3 Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application
9.3.1 Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2016-2021)
9.3.2 Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2022-2027)
9.3.3 Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2016-2027)
9.4 Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country
9.4.1 Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2016-2021)
9.4.2 Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (2016-2027)
10.2 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type
10.2.1 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2016-2027)
10.3 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application
10.3.1 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2016-2027)
10.4 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country
10.4.1 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
11.1.4 Merck Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2016-2021)
11.1.5 Merck Recent Development
11.2 Eisai
11.2.1 Eisai Company Details
11.2.2 Eisai Business Overview
11.2.3 Eisai Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
11.2.4 Eisai Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2016-2021)
11.2.5 Eisai Recent Development
11.3 ProStrakan
11.3.1 ProStrakan Company Details
11.3.2 ProStrakan Business Overview
11.3.3 ProStrakan Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
11.3.4 ProStrakan Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2016-2021)
11.3.5 ProStrakan Recent Development
11.4 Helsinn Holding
11.4.1 Helsinn Holding Company Details
11.4.2 Helsinn Holding Business Overview
11.4.3 Helsinn Holding Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
11.4.4 Helsinn Holding Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2016-2021)
11.4.5 Helsinn Holding Recent Development
11.5 Mundipharma
11.5.1 Mundipharma Company Details
11.5.2 Mundipharma Business Overview
11.5.3 Mundipharma Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
11.5.4 Mundipharma Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2016-2021)
11.5.5 Mundipharma Recent Development
11.6 Qilu Pharma
11.6.1 Qilu Pharma Company Details
11.6.2 Qilu Pharma Business Overview
11.6.3 Qilu Pharma Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
11.6.4 Qilu Pharma Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2016-2021)
11.6.5 Qilu Pharma Recent Development
11.7 Teva
11.7.1 Teva Company Details
11.7.2 Teva Business Overview
11.7.3 Teva Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
11.7.4 Teva Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2016-2021)
11.7.5 Teva Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
11.8.4 Novartis Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2016-2021)
11.8.5 Novartis Recent Development
11.9 Heron Therapeutics
11.9.1 Heron Therapeutics Company Details
11.9.2 Heron Therapeutics Business Overview
11.9.3 Heron Therapeutics Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
11.9.4 Heron Therapeutics Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2016-2021)
11.9.5 Heron Therapeutics Recent Development
11.10 Roche
11.10.1 Roche Company Details
11.10.2 Roche Business Overview
11.10.3 Roche Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
11.10.4 Roche Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2016-2021)
11.10.5 Roche Recent Development
11.11 Mylan
11.11.1 Mylan Company Details
11.11.2 Mylan Business Overview
11.11.3 Mylan Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
11.11.4 Mylan Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2016-2021)
11.11.5 Mylan Recent Development
11.12 Tesaro
11.12.1 Tesaro Company Details
11.12.2 Tesaro Business Overview
11.12.3 Tesaro Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
11.12.4 Tesaro Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2016-2021)
11.12.5 Tesaro Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of CINV
Table 3. Key Players of PONV
Table 4. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Regions (2016-2021)
Table 8. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Regions (2022-2027)
Table 10. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Trends
Table 11. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Drivers
Table 12. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Challenges
Table 13. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Restraints
Table 14. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Players (2016-2021)
Table 16. Global Top Chemotherapy-Induced Nausea and Vomiting (CINV) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) as of 2020)
Table 17. Ranking of Global Top Chemotherapy-Induced Nausea and Vomiting (CINV) Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Chemotherapy-Induced Nausea and Vomiting (CINV) Product Solution and Service
Table 21. Date of Enter into Chemotherapy-Induced Nausea and Vomiting (CINV) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Type (2016-2021)
Table 25. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Application (2016-2021)
Table 29. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2022-2027) & (US$ Million)
Table 61. Merck Company Details
Table 62. Merck Business Overview
Table 63. Merck Chemotherapy-Induced Nausea and Vomiting (CINV) Product
Table 64. Merck Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2016-2021) & (US$ Million)
Table 65. Merck Recent Development
Table 66. Eisai Company Details
Table 67. Eisai Business Overview
Table 68. Eisai Chemotherapy-Induced Nausea and Vomiting (CINV) Product
Table 69. Eisai Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2016-2021) & (US$ Million)
Table 70. Eisai Recent Development
Table 71. ProStrakan Company Details
Table 72. ProStrakan Business Overview
Table 73. ProStrakan Chemotherapy-Induced Nausea and Vomiting (CINV) Product
Table 74. ProStrakan Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2016-2021) & (US$ Million)
Table 75. ProStrakan Recent Development
Table 76. Helsinn Holding Company Details
Table 77. Helsinn Holding Business Overview
Table 78. Helsinn Holding Chemotherapy-Induced Nausea and Vomiting (CINV) Product
Table 79. Helsinn Holding Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2016-2021) & (US$ Million)
Table 80. Helsinn Holding Recent Development
Table 81. Mundipharma Company Details
Table 82. Mundipharma Business Overview
Table 83. Mundipharma Chemotherapy-Induced Nausea and Vomiting (CINV) Product
Table 84. Mundipharma Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2016-2021) & (US$ Million)
Table 85. Mundipharma Recent Development
Table 86. Qilu Pharma Company Details
Table 87. Qilu Pharma Business Overview
Table 88. Qilu Pharma Chemotherapy-Induced Nausea and Vomiting (CINV) Product
Table 89. Qilu Pharma Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2016-2021) & (US$ Million)
Table 90. Qilu Pharma Recent Development
Table 91. Teva Company Details
Table 92. Teva Business Overview
Table 93. Teva Chemotherapy-Induced Nausea and Vomiting (CINV) Product
Table 94. Teva Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2016-2021) & (US$ Million)
Table 95. Teva Recent Development
Table 96. Novartis Company Details
Table 97. Novartis Business Overview
Table 98. Novartis Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2016-2021) & (US$ Million)
Table 99. Novartis Recent Development
Table 100. Heron Therapeutics Company Details
Table 101. Heron Therapeutics Business Overview
Table 102. Heron Therapeutics Chemotherapy-Induced Nausea and Vomiting (CINV) Product
Table 103. Heron Therapeutics Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2016-2021) & (US$ Million)
Table 104. Heron Therapeutics Recent Development
Table 105. Roche Company Details
Table 106. Roche Business Overview
Table 107. Roche Chemotherapy-Induced Nausea and Vomiting (CINV) Product
Table 108. Roche Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2016-2021) & (US$ Million)
Table 109. Roche Recent Development
Table 110. Mylan Company Details
Table 111. Mylan Business Overview
Table 112. Mylan Chemotherapy-Induced Nausea and Vomiting (CINV) Product
Table 113. Mylan Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2016-2021) & (US$ Million)
Table 114. Mylan Recent Development
Table 115. Tesaro Company Details
Table 116. Tesaro Business Overview
Table 117. Tesaro Chemotherapy-Induced Nausea and Vomiting (CINV) Product
Table 118. Tesaro Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2016-2021) & (US$ Million)
Table 119. Tesaro Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Type: 2020 VS 2027
Figure 2. CINV Features
Figure 3. PONV Features
Figure 4. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Ambulatory Surgical Centers Case Studies
Figure 7. Diagnostic Centers Case Studies
Figure 8. Chemotherapy-Induced Nausea and Vomiting (CINV) Report Years Considered
Figure 9. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Regions: 2020 VS 2027
Figure 12. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Regions (2022-2027)
Figure 13. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Players in 2020
Figure 14. Global Top Chemotherapy-Induced Nausea and Vomiting (CINV) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in 2020
Figure 16. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Type (2016-2021)
Figure 17. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Type (2022-2027)
Figure 18. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Type (2016-2027)
Figure 20. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Application (2016-2027)
Figure 21. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Country (2016-2027)
Figure 22. United States Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Type (2016-2027)
Figure 26. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Application (2016-2027)
Figure 27. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Country (2016-2027)
Figure 28. Germany Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Region (2016-2027)
Figure 38. China Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Type (2016-2027)
Figure 46. Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Application (2016-2027)
Figure 47. Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Country (2016-2027)
Figure 48. Mexico Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Country (2016-2027)
Figure 54. Turkey Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Merck Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2016-2021)
Figure 58. Eisai Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2016-2021)
Figure 59. ProStrakan Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2016-2021)
Figure 60. Helsinn Holding Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2016-2021)
Figure 61. Mundipharma Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2016-2021)
Figure 62. Qilu Pharma Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2016-2021)
Figure 63. Teva Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2016-2021)
Figure 64. Novartis Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2016-2021)
Figure 65. Heron Therapeutics Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2016-2021)
Figure 66. Roche Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2016-2021)
Figure 67. Mylan Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2016-2021)
Figure 68. Tesaro Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
世界の化学療法誘発性悪心・嘔吐治療薬市場 2021：企業別、地域別、種類・用途別 The Chemotherapy-Induced Nausea and Vomiting Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opti…- 世界の術後悪心嘔吐（PONV）市場規模・現状・予測（2021年-2027年） The global post-operative nausea and vomiting (PONV) market is growing at a significant rate due to bourgeoning incidence rate of post-operative complications and increasing demand for combination therapy, as well as introduction of promising drugs in this segment across the globe. Major factors boo…
- 世界の術後悪心嘔吐（PONV）市場規模・現状・予測（2021年-2027年） The global post-operative nausea and vomiting (PONV) market is growing at a significant rate due to bourgeoning incidence rate of post-operative complications and increasing demand for combination therapy, as well as introduction of promising drugs in this segment across the globe. Major factors boo…
- 世界の化学療法誘発性貧血市場規模・現状・予測（2021年-2027年） Anaemia is a frequent complication of malignancy and is aggravated by chemotherapy. The key factor contributing to the growth of the global chemotherapy induced anemia market is the increase in the occurrence of cancer and anemia among geriatric patients. Market Analysis and Insights: Global Chemoth…
- 世界の化学療法誘発性血小板減少症治療市場規模・現状・予測（2021年-2027年） Cancer is a major chronic disease, which can be managed and treated by chemotherapy, radiation therapy, immunotherapy, hormone therapy, stem cell transplant, targeted therapy, and other therapies. Cancer can be treated by using one therapy or by using combination of therapies based on the stage, typ…